Professional Documents
Culture Documents
Case Study: SAN/CSIR Hoodia Benefit Sharing Model Dr Petro Terblanche Executive Director, CSIR Bio/Chemtek
The Cast
Biodiversity
CSIR Bio/Chemtek
nd a e ogy nc ol e ci h n S ec T
SA San Council
In d Kn igen o w ou l ed s ge
Hoodia
Three central principles: Conservation of biological diversity Sustainable use of its components Fair and equitable sharing of the benefits arising out of the utilization of genetic resources
Indigenous Knowledge
SA has a long tradition of medicinal use of indigenous plants >70% of South Africans consult a Traditional Healer; 200 000 healers active throughout country SA indigenous communities eg the San, has a wealth of unrecorded knowledge. (Considered the oldest genetic stock of contemporary humanity)
2001
UK newspaper reporter questions CSIR-Phytopharm-Pfizer P57 collaboration, without involvement of San CSIR and San meet regularly to share P57 information; involve independent experts in workshops; negotiate benefit sharing agreement
20022003
New chemical entity discovered, structure determined; Pre-clinical data for anti-obesity drug lead; New pharmaceutical formulation for obesity control
Phytopharm
The CSIR
Ancient knowledge relating to human use of Hoodia
The San
Challenges and lessons learnt from P57 Traditional Knowledge has intrinsic value, but requires significant value addition through technology/marketing to realise value Policy development benefits from real-life case studies (learn-on-the-run) Genetic resources common to more than one country
Acknowledgements
Dr Marthinus Horak (CSIR) Dr Vinesh Maharaj (CSIR) Dr Richard Dixey (Phytopharm) Various scientists SA San Council Roger Chennells (SAN Lawyer) Alida Britz (CSIR)
THANK YOU!